Reliability of the matson evaluation of drug side effects scale (MEDS)

Research in Developmental Disabilities

Volumn 19, Issue 6, 1998, Pages 501-506

  Matson, Johnny L ^a   Mayville, Erik A ^a   Bielecki, JoAnne ^a   Barnes, W Harvin ^a   Bamburg, Jay W ^a   Baglio, Christopher S ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT;

ADULT; AKATHISIA; ARTICLE; CARDIOVASCULAR DISEASE; DRUG INDUCED DISEASE; DYSKINESIA; EAR DISEASE; ENDOCRINE DISEASE; EYE DISEASE; GASTROINTESTINAL SYMPTOM; HUMAN; MAJOR CLINICAL STUDY; MALADJUSTMENT; MENTAL DEFICIENCY; MENTAL DISEASE; NOSE DISEASE; PARKINSONISM; PSYCHOMETRY; RELIABILITY; SKIN DEFECT;

ADULT; FEMALE; HUMANS; MALE; MENTAL RETARDATION; NEUROLOGIC EXAMINATION; OBSERVER VARIATION; PERSONALITY ASSESSMENT; PSYCHOMETRICS; PSYCHOTROPIC DRUGS; REPRODUCIBILITY OF RESULTS; SOCIAL BEHAVIOR DISORDERS;

EID: 0032212504     PISSN: 08914222     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-4222(98)00021-3     Document Type: Article

References (18)

1. Aman M., Kern R.A., Osborne P., Tumuluru R., Rojahn J., del Medico V. Fenfluramine and methylphenidate in children with mental retardation and borderline I.Q. Clinical effects . American Journal on Mental Retardation. 101:1997;521-534.
2. Aman M., Paxton J., Field C., Foote S. Prevalence of toxic anticonvulsant drug concentrations in mentally retarded persons with epilepsy. American Journal of Mental Deficiency. 90:1986;643-650.
3. Boyd R. Neuroleptic malignant syndrome and mental retardation Review and analysis of 29 cases . American Journal on Mental Retardation. 98:1993;143-155.
4. Campbell M., Adams P., Perry R., Spencer E., Overall J. Tardive and withdrawal dyskenesia in autistic children A prospective study . Psychopharmacology Bulletin. 24:1988;251-255.
5. Crocker L., Algina J. Introduction to classical and modern test theory. 1986;Harcourt Brace Jovanovich, Orlando, FL.
6. Gualtieri C. The problem of tardive akasthesia. Brain and Cognition. 23:1993;102-109.
7. Gualtieri C., Quade D., Hicks R., Mayo J., Schroeder S. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents. American Journal of Psychiatry. 141:1984;20-23.
8. Kalachnik J. Assessment sheet for Monitoring of Side-Effects System (MOSES). Poling A., Gadow K., Cleary J. Drug Therapy for Behavior Disorders An Introduction . 1986;153-155 Pergamon Press, New York.
9. Kalachnik J., Hanzel T., Harder S., Bauernfeind J., Engstrom E. Antiepileptic drug behavioral side effects in individuals with mental retardation and the use of behavioral measurement techniques. Mental Retardation. 33:1995;374-382.
10. Kalachnik J., Sprague R. The Dyskinesia Identification System Condensed User Scale (DISCUS) Reliability, validity, and a total score cut-off for mentally ill and mentally retarded populations . Journal of Clinical Psychology. 49:1993;177-189.
11. Lewis M.H., Aman M.G., Gadow K.D., Schroeder S.R., Thompson T. Psychopharmacology. Jacobson J.W., Mulick J.A. Manual of Diagnosis and Professional Practice in Mental Retardation. 1996;323-340 American Psychological Association, Washington DC.
12. Lewis M.H., MacLean W.E. Jr. Issues in treating emotional disorders. Matson J.L., Barrett R.P. Psychopathology in the Mentally Retarded. 1982;1-36 Grune and Stratton, New York.
13. Matson J.L. Depression in the mentally retarded A review . Education and Training in the Mentally Retarded. 17:1982;159-163.
14. Matson J.L., Sevin J.A. Theories of Dual Diagnosis in Mental Retardation. Journal of Consulting and Clinical Psychology. 62:1994;6-16.
15. National Institute of Mental Health (1985). Abnormal Involuntary Movement Scale (AIMS). Washington: Department of Health and Human Services, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration.
16. Reid A.H. Psychiatric disorders in mentally handicapped children A clinical follow-up study . Journal of Mental Deficiency Research. 24:1980;287-298.
17. Sachdev P., Loneragan C. The present status of akasthesia. The Journal of Nervous and Mental Disease. 179:1991;381-391.
18. Sprague R., Kalachnik J., Bruening S., Davis V., Ullmann R., Cullari S., Savidson N., Derguson D., Hoffner B. The Dyskinesia Identification System - Coldwater (DIS-Co) A tardive dyskinesia rating scale for the developmentally disabled . Psychopharmacology Bulletin. 20:1984;328-338.